TMEM30A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.021200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.694200E-01
Normal-vs-Stage2
5.520600E-01
Normal-vs-Stage3
2.068400E-01
Normal-vs-Stage4
4.636200E-01
Stage1-vs-Stage2
9.719000E-01
Stage1-vs-Stage3
4.848400E-01
Stage1-vs-Stage4
2.284800E-01
Stage2-vs-Stage3
4.026800E-01
Stage2-vs-Stage4
9.554000E-02
Stage3-vs-Stage4
3.024200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.753600E-01
Normal-vs-AfricanAmerican
9.531000E-01
Normal-vs-Asian
3.882000E-01
Caucasian-vs-AfricanAmerican
4.989200E-01
Caucasian-vs-Asian
3.788200E-01
AfricanAmerican-vs-Asian
3.147000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.449000E-01
Normal-vs-Female
7.049800E-01
Male-vs-Female
2.906000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.784600E-01
Normal-vs-Age(41-60Yrs)
9.912600E-01
Normal-vs-Age(61-80Yrs)
4.675800E-01
Normal-vs-Age(81-100Yrs)
3.776600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.958800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.538200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.753800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.595500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.396400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.500000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.570000E-01
Normal-vs-Daily Drinker
1.440580E-01
Normal-vs-Weekly Drinker
5.044200E-01
Normal-vs-Occasional Drinker
8.618400E-01
Normal-vs-Social Drinker
8.791800E-01
Non Drinker-vs-Daily Drinker
2.481000E-01
Non Drinker-vs-Weekly Drinker
5.518600E-01
Non Drinker-vs-Occasional Drinker
6.210400E-02
Non Drinker-vs-Social Drinker
2.355800E-01
Daily Drinker-vs-Weekly Drinker
1.642630E-01
Daily Drinker-vs-Occasional Drinker
1.042040E-02
Daily Drinker-vs-Social Drinker
5.156300E-02
Weekly Drinker-vs-Occasional Drinker
2.161000E-01
Weekly Drinker-vs-Social Drinker
5.076000E-01
Occasional Drinker-vs-Social Drinker
5.699400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.161200E-01
Normal-vs-Grade 2
1.696760E-01
Normal-vs-Grade 3
1.812230E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.464800E-01
Grade 1-vs-Grade 3
6.992800E-01
Grade 1-vs-Grade 4
2.161200E-01
Grade 2-vs-Grade 3
3.612000E-01
Grade 2-vs-Grade 4
1.696760E-01
Grade 3-vs-Grade 4
1.812230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.168600E-01
Normal-vs-NonDiabetic
5.187200E-01
Diabetic-vs-NonDiabetic
5.536000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.659760E-01
Normal-vs-NoPancreatitis
5.580800E-01
Pancreatitis-vs-NoPancreatitis
1.620580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.373000E-01
Normal-vs-N1
5.993800E-01
N0-vs-N1
9.596800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.480600E-01
Normal-vs-TP53-NonMutant
7.708000E-01
TP53-Mutant-vs-TP53-NonMutant
5.620200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
